baclofen sintetica 2 mg/ml infúzny roztok
sintetica gmbh, nemecko - baklofén - 63 - myorelaxantia
baclofen sintetica 0,5 mg/ml infúzny roztok
sintetica gmbh, nemecko - baklofén - 63 - myorelaxantia
baclofen sintetica 0,05 mg/ml injekčný roztok
sintetica gmbh, nemecko - baklofén - 63 - myorelaxantia
sinora 1 mg/ml infúzny koncentrát
sintetica gmbh, nemecko - norepinefrín (noradrenalín) - 78 - sympathomimetica
sinora 0,2 mg/ml infúzny roztok
sintetica gmbh, nemecko - norepinefrín (noradrenalín) - 78 - sympathomimetica
sinora 0,1 mg/ml infúzny roztok
sintetica gmbh, nemecko - norepinefrín (noradrenalín) - 78 - sympathomimetica
prilotekal 20 mg/ml injekčný roztok
b.braun melsungen ag, nemecko - prilokaín - 01 - anaesthetica (lokÁlne)
ampres 20 mg/ml
b.braun melsungen ag, nemecko - chlórprokaín - 01 - anaesthetica (lokÁlne)
ampres 10 mg/ml
b.braun melsungen ag, nemecko - chlórprokaín - 01 - anaesthetica (lokÁlne)
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochloride - phenylketonurias - iné alimentárny trakt a metabolizmus výrobky, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.